usdaed

If the worst does happen, and the market decides to take its existential nap, it’s crucial to keep your wits-and your investments-intact. Companies wobbling on shaky legs are destined for the dustbin when the storm hits. Conversely, the ones with grit, gumption, and enough cash reserves tend to rebound faster than you can say “buy low, sell high.” And, in that unlikely event, there’s one ETF from Vanguard I intend to cling to like a life raft-because I’ve learned, after enough missteps and market tantrums, that there’s value in steady, quiet resilience.

The paperwork calls it a “Rule 10b5-1 trading plan.” A bureaucratic shrug. Executives sell shares; markets twitch. The world continues.

The volume may sit within Mr. Gilboa’s newly observed pattern, but that presumes we ignore the broader picture. Previous sales have averaged about 85,000 shares-still a significant stake, but this particular sale clears nearly half his direct holdings. It signals not just liquidity but perhaps a subtle signal of his confidence in overextended valuation.

S&P Global Market Intelligence says it all: 11% down, folks. A number that makes you question if you’ve accidentally sold your kidney to a shadowy figure on the internet. And the chart? A Jackson Pollock painting if ever there was one. Up, down, sideways-Arm spent most of the year pretending it wasn’t worried about an AI bubble, which, honestly, is like ignoring the elephant in the room… while the elephant texts you passive-aggressive tweets.

The stock’s 28% gain over the past year isn’t just a fluke-it’s a calculated slap in the face to the industry’s outdated playbook. Analysts are now penciling in $69-$78 per share as a price target, which is generous considering the company’s current valuation is still low enough to qualify as “undervalued.” But let’s not get ahead of ourselves. The real story here isn’t the numbers-it’s the sheer audacity of choosing to ignore a market everyone else thought was a sure thing.

The journey, however, was not without its stumbles. As the chart below illustrates, the stock’s trajectory resembled a particularly spirited waltz, with a sharp dip from its October peak. Yet, even in its most dramatic pirouette, it retained enough élan to finish the year in the black.

The dream of U.S. oil companies repairing Venezuela’s “antiquated infrastructure” is a siren song. Thirty billion barrels of crude sleep beneath the earth, yet the machinery to extract them rusts in the sun, victims of Chávez’s nationalization and Maduro’s misrule. To revive this slumbering giant, fortunes must be spent-$100 billion to $200 billion over a decade, if one believes the analysts. It is the price of resurrecting a corpse, and the corpse may yet reject the lifeblood offered.